Buys
Open market- Shares
- Avg price
- Total value
Michelle Renee Griffin - Director at Adaptive Biotechnologies Corp
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- ADPT on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Michelle Renee Griffin in Adaptive Biotechnologies Corp
Sells
Open market- Shares
- -115,522
- Avg price
- $17.31
- Total value
- -$2,000,259
Net
Past year- Shares
- -115,522
- Share %
- -100%
- Total value
- -$2,000,259
Reported holdings for Michelle Renee Griffin in Adaptive Biotechnologies Corp
Form 4 holding
Director
Adaptive Biotechnologies Corp
- Security class
- Common Stock
- Shares / value
- 15,625
- Estimated value
- $315,312
- Report date
- 25 Jun 2026
- Price
- $20.18
- Ownership
- Direct
Form 4 holding
Director
Adaptive Biotechnologies Corp
- Security class
- Stock Option (right to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 25 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Michelle Renee Griffin in Adaptive Biotechnologies Corp
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.